Skip to content

Epstein-Barr Virus (EBV) Nuclear Antigen IgG Antibody, Serum

Published: August 9, 2026Updated: August 16, 2026

This test measures your body’s immune response to the Epstein-Barr virus (EBV), a common virus that can cause infections like mononucleosis. It helps determine if you’ve been exposed to EBV and whether your immune system has developed antibodies against it.

Quick summary

["This test helps track past or current EBV infection and immune response."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
23970-7
Short code
EBV NA IgG Titr CSF
Synonyms
EBV NA IgG Titr CSF
Category
chemistry
Sample
csf
Container
Sterile tube
Units
N/A
Ref low
8
Ref high
61
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
CPT
82977
SNOMED
3110003
Specimen volume
1-2 mL
Stability
Immediate analysis required, Refrigerated: 1h
Hemolysis max
200
TAT
4–24 hours
Order
routine

Why This Test Is Done

Your healthcare provider may order this test if you have symptoms of EBV infection, such as fatigue, sore throat, or swollen lymph nodes. It can also be used to monitor chronic conditions like infectious mononucleosis or to assess immune function in certain situations.

What to Expect Before the Test

No special preparation is needed. You’ll provide a blood sample, usually drawn from your arm. The test involves a small needle, and you may feel a brief pinch. If you’re pregnant, have a bleeding disorder, or take blood-thinning medications, let your provider know before the test.

What the Test Results Mean

Positive results indicate you’ve been exposed to EBV and developed IgG antibodies, which typically remain in your system for life. Negative results suggest no current EBV exposure or insufficient antibody presence. Results alone don’t diagnose EBV; they’re used alongside clinical findings.

Common Causes of Positive Results

Positive results are common in people who have recovered from EBV infection, such as those with mononucleosis. They may also appear in individuals with chronic EBV carriers or those with certain immune-related conditions.

Reference range

Adult males: 8-61 U/L; Adult females: 5-36 U/LN/A

Specimen: csf

No special preparation required. Avoid fatty meals before the test if possible.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Short name

EBV IgG Antibody

Frequently asked questions

How long does it take to get results from this test?
Results are usually available within 1 to 3 business days, depending on lab processing times. Your healthcare provider will discuss the results with you during your follow-up visit.
Can I have this test if I’m pregnant?
Yes, this test is generally safe during pregnancy. However, always inform your healthcare provider about any medical conditions or medications you’re taking before the test to ensure safety.
What does a high or low antibody level mean?
A high IgG level means you’ve likely had EBV exposure and recovered. A low or negative level suggests no current EBV exposure or insufficient immune response. Consult your provider for interpretation based on your symptoms and medical history.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy